U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342439) titled 'Study of Serine Supplementation to Protect Vision in MacTel' on Jan. 07.
Brief Summary: The goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional changes of the retina in people with MacTel type 2. The main questions it aims to answer are:
* Does serine slow the progression of MacTel?
* Is long-term serine supplementation safe in people with MacTel? Researchers will compare serine to a placebo (a look-alike substance that contains no drug) to see if serine works to slow the progression of MacTel.
Participants will:
* Take serine or ...